高级检索
当前位置: 首页 > 详情页

Chinese herbal medicine for atopic dermatitis: A systematic review

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

机构: [a]Traditional and Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, Royal Melbourne Institute of Technology University, Bundoora Campus, Victoria, Australia, [b]the Guangdong Provincial Hospital of Chinese Medicine,Guangzhou, China.
出处:
ISSN:

关键词: allergy alternative and complementary medicine atopic dermatitis Chinese herbal medicine eczema systematic review

摘要:
Background: Atopic dermatitis (AD) is a chronic, itching skin disease, and conventional therapies offer inadequate symptom management. Patients with AD are increasingly turning to Chinese medicine. Objective: We systematically evaluated the clinical evidence of the efficacy and safety of oral Chinese herbal medicine for AD. Methods: Searches were conducted on major electronic databases using the following key words: "randomized controlled trials," "atopic dermatitis," "traditional Chinese medicine," "traditional East Asian medicine," "herbal medicine," "Chinese herbal drugs," "medicinal plants," "phytotherapy," "Kampo medicine," and "Korean traditional medicine." The results were screened to include English/Chinese randomized controlled trials. A metaanalysis was conducted on suitable outcome measures. Results: Seven randomized controlled trials were included (1 comparing Chinese herbal medicine and Western medicine with Western medicine alone; 6 comparing Chinese herbal medicine with placebo). Combined Chinese herbal medicine with Western medicine was superior to Western medicine alone. Three placebo controlled trials showed significant treatment efficacy and 2 showed significantly reduced concurrent therapy with Chinese herbal medicine. No abnormalities in safety profile or severe adverse events were reported. Limitations: A metaanalysis of all included studies could not be conducted because of study heterogeneity. Conclusions: Chinese herbal medicine significantly improved symptom severity of AD and was reported as well tolerated. However, the poor quality of studies did not allow for valid conclusions to support its tolerability and routine use. Additional studies addressing the methodologic issues are warranted to determine the therapeutic benefit of Chinese herbal medicine for AD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 2 区 医学
小类 | 2 区 皮肤病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 皮肤病学
JCR分区:
出版当年[2011]版:
Q1 DERMATOLOGY
最新[2023]版:
Q1 DERMATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [a]Traditional and Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, Royal Melbourne Institute of Technology University, Bundoora Campus, Victoria, Australia,
通讯作者:
通讯机构: [a]Traditional and Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, Royal Melbourne Institute of Technology University, Bundoora Campus, Victoria, Australia, [*1]Traditional and Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, RMIT University, Bundoora, VIC 3083, Australia.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号